Safety and tolerability of 13-valent pneumococcal conjugate vaccine in the elderly

References

• Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012; 61:816 - 9; PMID: 23051612
   PubMedGoogle Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67:71 - 9; http://dx.doi.org/10.1136/thx.2009.129502; PMID: 20729232
   PubMed Web of Science ®Google Scholar
• Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64:1062 - 9; http://dx.doi.org/10.1136/thx.2008.109785; PMID: 19454409
   PubMed Web of Science ®Google Scholar
• Jackson LA, Janoff EN. Pneumococcal vaccination of elderly adults: new paradigms for protection. Clin Infect Dis 2008; 47:1328 - 38; http://dx.doi.org/10.1086/592691; PMID: 18844484
   PubMed Web of Science ®Google Scholar
• Weycker D, Strutton D, Edelsberg J, Sato R, Jackson LA. Clinical and economic burden of pneumococcal disease in older US adults. Vaccine 2010; 28:4955 - 60; http://dx.doi.org/10.1016/j.vaccine.2010.05.030; PMID: 20576535
   PubMed Web of Science ®Google Scholar
• Durando P, Faust SN, Fletcher M, Krizova P, Torres A, Welte T. Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults. Clin Microbiol Infect 2013; 19:Suppl 1 1 - 9; http://dx.doi.org/10.1111/1469-0691.12320; PMID: 24083785
   PubMed Web of Science ®Google Scholar
• Fedson DS, Nicolas-Spony L, Klemets P, van der Linden M, Marques A, Salleras L, Samson SI. Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe. Expert Rev Vaccines 2011; 10:1143 - 67; http://dx.doi.org/10.1586/erv.11.99; PMID: 21810065
   PubMed Web of Science ®Google Scholar
• Alicino C, Barberis I, Orsi A, Durando P. Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13 - valent polysaccharide conjugate vaccine. Minerva Med 2014; 105:89 - 97; PMID: 24572454
   PubMed Web of Science ®Google Scholar
• Raymond F, Boucher N, Allary R, Robitaille L, Lefebvre B, Tremblay C, Corbeil J, Gervaix A. Serotyping of Streptococcus pneumoniae based on capsular genes polymorphisms. PLoS One 2013; 8:e76197; http://dx.doi.org/10.1371/journal.pone.0076197; PMID: 24086706
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012. MMWR Morb Mortal Wkly Rep 2013; 62:308 - 11; PMID: 23615674
   PubMed Web of Science ®Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; 1:CD000422; PMID: 18253977
   PubMed Web of Science ®Google Scholar
• Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2013; 1:CD000422; PMID: 23440780
   PubMed Web of Science ®Google Scholar
• Walters JA, Smith S, Poole P, Granger RH, Wood-Baker R. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010; 11:CD001390; PMID: 21069668
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. 22 September 2011 EMA/CHMP/763049/2011 Committee for Medicinal Products for Human Use (CHMP) Available from http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR Morb Mortal Wkly Rep 2012; 61:394 - 5; PMID: 22647745
   PubMedGoogle Scholar
• Jackson LA, Gurtman A, Rice K, Pauksens K, Greenberg RN, Jones TR, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. Vaccine 2013; 31:3585 - 93; http://dx.doi.org/10.1016/j.vaccine.2013.05.010; PMID: 23688527
   PubMed Web of Science ®Google Scholar
• Schwarz TF, Flamaing J, Rümke HC, Penzes J, Juergens C, Wenz A, Jayawardene D, Giardina P, Emini EA, Gruber WC, et al. A randomized, double-blind trial to evaluate immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given concomitantly with trivalent influenza vaccine in adults aged ≥65 years. Vaccine 2011; 29:5195 - 202; http://dx.doi.org/10.1016/j.vaccine.2011.05.031; PMID: 21619909
   PubMed Web of Science ®Google Scholar
• Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age. Vaccine 2014; 32:2364 - 74; http://dx.doi.org/10.1016/j.vaccine.2014.02.002; PMID: 24606865
   PubMed Web of Science ®Google Scholar
• Clutterbuck EA, Lazarus R, Yu LM, Bowman J, Bateman EA, Diggle L, Angus B, Peto TE, Beverley PC, Mant D, et al. Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells. J Infect Dis 2012; 205:1408 - 16; http://dx.doi.org/10.1093/infdis/jis212; PMID: 22457293
   PubMed Web of Science ®Google Scholar
• Fitzwater SP, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012; 31:501 - 8; http://dx.doi.org/10.1097/INF.0b013e31824de9f6; PMID: 22327872
   PubMed Web of Science ®Google Scholar
• Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CGUS. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369:155 - 63; http://dx.doi.org/10.1056/NEJMoa1209165; PMID: 23841730
   PubMed Web of Science ®Google Scholar
• Ansaldi F, de Florentiis D, Canepa P, Ceravolo A, Rappazzo E, Iudici R, Martini M, Botti G, Orsi A, Icardi G, et al. Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation. Hum Vaccin Immunother 2013; 9:614 - 20; http://dx.doi.org/10.4161/hv.23253; PMID: 23292052
   PubMed Web of Science ®Google Scholar
• Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM, Gruber WC, Tansey S, McDonough A, Thoma B, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66:378 - 83; PMID: 18990781
   PubMed Web of Science ®Google Scholar
• Bonten M, Bolkenbaas M, Huijts S, Webber C, Gault S, Gruber W, et al. Community acquired pneumonia immunisation trial in adults (CAPITA), ISPPD-9/pneumonia 2014 Mar 9-13;3:1-286.
   Google Scholar
• Deliberation of the Regional Council 19/07/2013 n. 891 Regional Plan preventable by vaccination. Official Bulletin of the Region of Liguria Prevention of pneumococcal disease in adults older than 64 years and in young people and adults with factors risk-operative instructions. prot. n. PG/2013
   Google Scholar
• European Medicine Agency. Prevenar. Summary of product characteristics. Available from http://www.ema.europa.eu/docs/it_IT/document_library/EPAR_-_Product_Information/human/001104/WC500057247.pdf
   Google Scholar
• Durando P, Alicino C, Alberti M, Sticchi L, Turello V, Marensi L, Caiazzo AL, Panico MG, Giugliano F, Parlato A, et al, Italian Intradermal Influenza Vaccine Working Group. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study. Adv Ther 2012; 29:312 - 26; http://dx.doi.org/10.1007/s12325-012-0012-1; PMID: 22529024
   PubMed Web of Science ®Google Scholar